<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Xu H</submitter><funding>Howard Hughes Medical Institute</funding><funding>National Institutes of Health</funding><funding>Cancer Research Institute</funding><funding>Helen and Martin Kimmel Center for Biology and Medicine</funding><pagination>e20210777</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8421263</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>218(11)</volume><pubmed_abstract>TGF-β signaling is fundamental for both Th17 and regulatory T (Treg) cell differentiation. However, these cells differ in requirements for downstream signaling components, such as SMAD effectors. To further characterize mechanisms that distinguish TGF-β signaling requirements for Th17 and Treg cell differentiation, we investigated the role of Arkadia (RNF111), an E3 ubiquitin ligase that mediates TGF-β signaling during development. Inactivation of Arkadia in CD4+ T cells resulted in impaired Treg cell differentiation in vitro and loss of RORγt+FOXP3+ iTreg cells in the intestinal lamina propria, which increased susceptibility to microbiota-induced mucosal inflammation. In contrast, Arkadia was dispensable for Th17 cell responses. Furthermore, genetic ablation of two Arkadia substrates, the</pubmed_abstract><journal>The Journal of experimental medicine</journal><pubmed_title>Arkadia-SKI/SnoN signaling differentially regulates TGF-β-induced iTreg and Th17 cell differentiation.</pubmed_title><pmcid>PMC8421263</pmcid><funding_grant_id>2R01AI080885</funding_grant_id><pubmed_authors>Raghavan V</pubmed_authors><pubmed_authors>Nguyen HH</pubmed_authors><pubmed_authors>Episkopou V</pubmed_authors><pubmed_authors>Littman DR</pubmed_authors><pubmed_authors>Wu L</pubmed_authors><pubmed_authors>Mesa KR</pubmed_authors><pubmed_authors>Xu H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Arkadia-SKI/SnoN signaling differentially regulates TGF-β-induced iTreg and Th17 cell differentiation.</name><description>TGF-β signaling is fundamental for both Th17 and regulatory T (Treg) cell differentiation. However, these cells differ in requirements for downstream signaling components, such as SMAD effectors. To further characterize mechanisms that distinguish TGF-β signaling requirements for Th17 and Treg cell differentiation, we investigated the role of Arkadia (RNF111), an E3 ubiquitin ligase that mediates TGF-β signaling during development. Inactivation of Arkadia in CD4+ T cells resulted in impaired Treg cell differentiation in vitro and loss of RORγt+FOXP3+ iTreg cells in the intestinal lamina propria, which increased susceptibility to microbiota-induced mucosal inflammation. In contrast, Arkadia was dispensable for Th17 cell responses. Furthermore, genetic ablation of two Arkadia substrates, the</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2025-04-05T14:05:25.584Z</modification><creation>2025-04-05T14:05:25.584Z</creation></dates><accession>S-EPMC8421263</accession><cross_references><pubmed>34473197</pubmed><doi>10.1084/jem.20210777</doi></cross_references></HashMap>